Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, Caio Fernando Ferreira Coêlho, Jan Wenzel, Corentin Bedart, Charlotte Izabelle, Sarah Gallet, Sophie Le Poder, Bernard Klonjkowski, Markus Schwaninger, Vincent Prévot, Julie Dam, Ralf Jockers
Topics & Concepts
MelatoninMedicineVirusPharmacologyImmune systemInflammationViral entryImmunologyInternal medicineViral replicationLong-Term Effects of COVID-19Circadian rhythm and melatoninCOVID-19 and Mental Health